Clinical Site

Los Angeles, California 90404

2 studies enrolling now · 11 studies all time

What they study most

Acne Inversa, Cardiovascular Disease, Celiac Disease, Diabetes Mellitus, Type 2, Diabetic Foot Ulcer, Elevated Lipoprotein(a), Fatty Liver, Nonalcoholic, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Hypertriglyceridemia, NAFLD, Respiratory Syncytial Virus Infections

Studies at this site

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia — Completed
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed
• A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers — Status unconfirmed